TY  - BOOK
AU  - Stefanie Hochhold
PY  - 2021
CY  - Berlin, Germany
PB  - Peter Lang Verlag
SN  - 0531-7339
TI  - Venture Capital and Corporate Venture Capital in Financing Biotech Companies
UR  - https://www.peterlang.com/document/1108220
N2  - This book offers insights into three different aspects of financing companies with venture capital (VC) and corporate venture capital (CVC) using three independent and specific datasets. First the study analyses particular VC financing mechanisms depending on differences in the national institutional framework and the experience of the VC investor. The question whether the actual value-adding ability of VC investments in contrast to CVC investments differs from a portfolio company’s perspective is discussed in the second chapter. Finally, the time-dependent performance of CVC investments is analysed.
KW  - Biotechnology, portfolio company, time-dependent performance, financing mechanisms
LA  - English
ER  -